Pelago

We are thrilled to announce our $58 million Series C funding round with some of the world’s most progressive investors! Substance use management has moved from a niche solution to an essential benefit, and this funding opens a new chapter of enhanced services and innovative solutions for our clients and members. To our clients, partners, and members, we deeply appreciate your unwavering support and trust. Thank you for joining us on our journey to break down barriers to substance use care that works. Read our full press release: https://hubs.la/Q02r24L50 #SubstanceUseManagement #Pelago

On Thursday August 8, 2024 we’re partnering with apree health to discuss how to create a healthier, more productive workforce by using practical steps to improve health equity while finding cost savings. Our speakers feature Pelago Medical Director, Justin Yang, MD, MPH, FACP and apree health Chief Medical Officer, Kevin Wang, M.D. Join us to learn: 👉 Why generic care falls short for treating substance use disorders 👉 How targeted care improves outcomes and reduces costs 👉 Ways to empower employees with clinically-backed information to make informed health decisions Register now: https://hubs.la/Q02HXwC60

At Pelago, we’re proud to partner with companies like Lumen Technologies to support employees in achieving healthier lifestyles. Today, we are sharing an inspiring story from Lumen and one of their employees, who transformed her life and drinking habits with Pelago. For employers like Lumen, investing in substance use management isn’t just about reducing costs—it’s about nurturing a healthier, more productive workforce. And their commitment to employee wellbeing yields results: ✅ 34% enrollment rate ✅ 2.1 ROI ✅ 46% of cost savings from lower in- patient costs We are proud to be part of these transformative journeys and to help our members achieve their goals, both personally and professionally.

We are excited to share the groundbreaking results of our 13th peer-reviewed study, the first to evaluate the effectiveness of a digital therapeutic intervention for opioid use disorder using medication-assisted treatment and cognitive behavioral therapy. This study highlights the power of our virtual substance use management program in overcoming stigma and other barriers to access through nationwide, confidential substance use treatment. The results, including a 67% days-abstinent rate over 90 days, further strengthen the case for extending telehealth prescribing flexibilities for OUD treatment. Read more about our latest study: https://hubs.ly/Q02GXqGl0 #DigitalHealth #Telehealth #EmployeeBenefits

Last week, Pelago Chief Scientific Officer, Suzette Glasner, Ph.D. celebrated the launch of her second book, “Addiction: What Everyone Needs to Know,” with a signing party in LA. Thank you to everyone who came out to support her and join the discussion about substance use. In her latest work, Dr. Glasner combines her extensive research and clinical experience to address the most pressing questions about addiction, including the biological, psychological, and social aspects of addiction, as well as the latest treatment approaches and policy considerations. She aims to provide readers with a clear and comprehensive understanding of addiction, grounded in the latest scientific research. Read more about the book and where you can find it here: https://hubs.ly/Q02GdLwL0

In last week's webinar, Eric Long from Beacon Health System joined us to share insights on the interconnected nature of substance use disorders. Eric highlighted that while tobacco cessation is often less stigmatized and easier to seek help for, it can frequently reveal other underlying substance use disorders. This emphasizes the importance of providing comprehensive care that goes beyond tobacco cessation to address the full spectrum of substance use. Watch the full webinar here: https://hubs.la/Q02G0cT00

Congratulations to Pelago's Chief Scientific Officer, Suzette Glasner, Ph.D., on the launch of her latest book "Addiction: What Everyone Needs to Know". “Addiction is a complex and often misunderstood condition. My goal with this book is to provide readers with a clear and comprehensive understanding of addiction, grounded in the latest scientific research. I hope it will serve as a valuable resource for anyone seeking to learn more about this critical issue.” Read more about Dr. Glasner's book here: https://hubs.la/Q02DSBq40

📣 Upcoming webinar! Join us next Tuesday, July 2, as we discuss the complexities of treating SUDs and the financial impact that dedicated substance use treatment provides to employers. Beacon Health System Manager, Disease/Pharmacist, Eric Long joins Pelago CEO & Co-founder, Yusuf Sherwani, M.D. to share their journey with Pelago’s substance use management solution and the impactful cost savings, outcomes, and engagement results. Register now: https://hubs.la/Q02DsH_h0 #SubstanceUseManagement #EmployeeBenefits

Pelago Chief Scientific Officer, Suzette Glasner, Ph.D., will be at Behavioral Health Business Addiction & Autism Treatment Forum in Chicago. Join her on July 18 at 1pm CT as she shares her insights into measurement-backed innovations helping SUD providers achieve better outcomes. If you're not already registered, you can buy tickets here: https://hubs.la/Q02Dtyzd0

🤝 Underscoring the connection between oral health and total health, Guardian Life has partnered with StartUp Health company Pelago to include tobacco cessation in workplace-sponsored dental insurance. Pelago will guide and support individuals through a personalized and confidential tobacco cessation program leveraging digital solutions and human coaching. #HealthTransformer #HealthMoonshot Read more ⤵️ https://ow.ly/LBTl50Souui